Quarterly loss grows at Novavax -- Gazette.Net


ADVERTISEMENT


ADVERTISEMENT


ADVERTISEMENT


RECENTLY POSTED JOBS



FEATURED JOBS


Loading...


Share on Facebook
Share on Twitter
Delicious
E-mail this article
Leave a Comment
Print this Article
advertisement

Rockville vaccine developer Novavax reported that its second-quarter net loss widened to $17.9 million, from $12.6 million in the second quarter of 2013.

However, revenues grew to $8.3 million, from $3.5 million.